For the purposes of regulation 47(1)(f), a pharmacist may sell or supply a Schedule 4 poison to a person without a prescription if—
(a) the pharmacist considers that the sale or supply is necessary to ensure continuity of treatment; and
Reg. 57(b) amended by S.R. No. 112/2022 reg. 6.
(b) the Schedule 4 poison is listed in the National Health (Continued Dispensing) Determination 2022; and
Reg. 57(c) amended by S.R. No. 112/2022 reg. 6.
(c) the sale or supply complies with the conditions in the National Health (Continued Dispensing) Determination 2022; and
(d) the Minister has approved under regulation 159 the sale or supply of that poison without a prescription; and
(e) the pharmacist has not previously sold or supplied the Schedule 4 poison to the patient in accordance with this regulation in the previous 12 months.
Reg. 57A inserted by S.R. No. 105/2023 reg. 5.